BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Concortis Biosystems' David Miao Will Present at the World ADC Summit Conference in San Francisco


10/11/2013 11:05:33 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

San Diego, CA, Oct.11, 2013 - Concortis Biosystems, a leader in ADC technology and a global service provider announced that David Miao, Founder and CSO will present at the World ADC Summit Conference in San Francisco, on October 16.

Dr. Miao, Concortis founder and CSO will speak about selective conjugation technologies and will discuss the advantages of the K-LockTM and C-LockTM and their use in generating antibody-drug conjugates with superior profiles. In addition he will present results indicating that Concortis’s conjugation technologies open new avenues to advance conventional ADC-1x to multifunctional ADC-2x, including the precise stoichiometric conjugation of an antibody with two different drug payloads.

About Concortis Biosystems Corp.

Privately held Concortis Biosystems is a leader in ADC technologies with commanding expertise in payloads and linkers as well as in-depth know -how in conjugation technology. Our state of the art R&D facility is located in the heart of Biotech Beach, San Diego and currently houses a staff of 12 scientists, nine of them are senior PhD scientists with averaging more than 10 years in antibody research and bio-conjugation chemistry. Since 2011 Concortis has entered into a number of research collaborations to empower antibodies with the optimal combinations of payloads and conjugation methods. Our profound knowledge of ADC has made us the partner of choice for creating ADC.

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES